SonoScape Medical Corp. (300633.SZ)
CNY 31.8
(-0.31%)
CNY 31.8
(-0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.12 Billion | 1.76 Billion | 1.44 Billion | 1.16 Billion | 1.25 Billion | 1.22 Billion |
| Cost of Revenue | 648.55 Million | 584.04 Million | 471.2 Million | 390.27 Million | 435.27 Million | 369.59 Million |
| Gross Profit | 1.47 Billion | 1.17 Billion | 973.39 Million | 772.81 Million | 818.57 Million | 857.25 Million |
| Operating Expenses | 996.88 Million | 770.59 Million | 654.22 Million | 571.09 Million | 680.07 Million | 581.18 Million |
| Selling, General and Administrative Expenses | 551.23 Million | 446.67 Million | 393.27 Million | 345.26 Million | 429.68 Million | 371.82 Million |
| Research and Development Expenses | 384.25 Million | 328.95 Million | 263.05 Million | 237.41 Million | 254.91 Million | 233.48 Million |
| Other Expenses | -35.67 Million | -3.36 Million | 38.52 Million | -1.9 Million | 1.26 Million | -562.66 Thousand |
| Cost and Expenses | 1.64 Billion | 1.35 Billion | 1.12 Billion | 961.36 Million | 1.11 Billion | 950.77 Million |
| Operating Income | 474.81 Million | 382.42 Million | 215.66 Million | -44.17 Million | 106.61 Million | 271.72 Million |
| Interest Expense | 8.82 Million | 3.7 Million | 5.55 Million | 17.54 Million | 16.18 Million | 2.57 Million |
| Income Tax Expense | 19.39 Million | 12.13 Million | 6.96 Million | 1.72 Million | 6.15 Million | 18.73 Million |
| Earnings before Tax | 473.83 Million | 381.94 Million | 254.21 Million | -44.53 Million | 107.69 Million | 271.35 Million |
| Net Income | 454.43 Million | 369.8 Million | 247.24 Million | -46.26 Million | 101.53 Million | 252.62 Million |
| Earnings Per Share Basic | 1.06 | 0.86 | 0.62 | -0.12 | 0.25 | 0.63 |
| Earnings Per Share Diluted | 1.05 | 0.86 | 0.62 | -0.12 | 0.25 | 0.63 |
| Weighted Average Shares Outstanding | 428.71 Million | 427.86 Million | 400.01 Million | 400.01 Million | 400.01 Million | 400.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 432.79 Million | 427.86 Million | 400.01 Million | 400.01 Million | 400.01 Million | 400.99 Million |
| Gross Margin | 0.69 | 0.67 | 0.67 | 0.66 | 0.65 | 0.70 |
| EBIT Margin | 0.26 | 0.28 | 0.29 | 0.21 | 0.15 | 0.26 |
| Profit Margin | 0.21 | 0.21 | 0.17 | -0.04 | 0.08 | 0.21 |
| EBITDA | 544.91 Million | 439.01 Million | 319.93 Million | 8.76 Million | 154.64 Million | 293.12 Million |
| Earnings Before Tax Margin | 0.22 | 0.22 | 0.15 | -0.04 | 0.09 | 0.22 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 385.5 Million | 533.35 Million | 474.98 Million | 652.41 Million | 2.12 Billion | 424.49 Million |
| Cost of Revenue | 137.34 Million | 183.16 Million | 146.68 Million | 189.46 Million | 648.55 Million | 135.46 Million |
| Gross Profit | 248.15 Million | 350.18 Million | 328.3 Million | 462.95 Million | 1.47 Billion | 289.02 Million |
| Operating Expenses | 316.43 Million | 280.85 Million | 266.74 Million | 318.4 Million | 963.27 Million | 227.51 Million |
| Selling, General and Administrative Expenses | 432.72 Million | 146.09 Million | 165.1 Million | 113.57 Million | - | 192.7 Million |
| Research and Development Expenses | 126.12 Million | 110.54 Million | 101.63 Million | 120.63 Million | - | 93.82 Million |
| Other Expenses | -242.41 Million | 870.09 Thousand | 503.15 Thousand | -1.75 Million | -2.54 Million | 17.18 Million |
| Cost and Expenses | 453.78 Million | 464.01 Million | 413.43 Million | 507.86 Million | 1.61 Billion | 362.97 Million |
| Operating Income | -61.1 Million | 65.77 Million | 61.55 Million | 125.07 Million | 474.81 Million | 58.61 Million |
| Interest Expense | 2.23 Million | 1.56 Million | 841.32 Thousand | 669.61 Thousand | 5.05 Million | 1 Million |
| Income Tax Expense | 547.75 Thousand | -5.28 Million | 11.34 Million | -8.92 Million | 19.39 Million | 10.5 Million |
| Earnings before Tax | -61.03 Million | 65.09 Million | 111.53 Million | 124.89 Million | 473.83 Million | 58.06 Million |
| Net Income | -61.58 Million | 70.38 Million | 100.19 Million | 133.82 Million | 454.43 Million | 47.55 Million |
| Earnings Per Share Basic | -0.14 | 0.16 | 0.23 | 0.31 | - | 0.11 |
| Earnings Per Share Diluted | -0.14 | 0.16 | 0.23 | 0.31 | - | 0.11 |
| Weighted Average Shares Outstanding | 432.49 Million | 430.63 Million | 430.74 Million | 429.41 Million | 428.71 Million | 430.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 432.49 Million | 434.19 Million | 432.22 Million | 436.32 Million | 432.79 Million | 432.73 Million |
| Gross Margin | 0.64 | 0.66 | 0.69 | 0.71 | 0.69 | 0.68 |
| EBIT Margin | -0.15 | 0.16 | 0.25 | 0.23 | - | 0.17 |
| Profit Margin | -0.16 | 0.13 | 0.21 | 0.21 | 0.21 | 0.11 |
| EBITDA | -58.8 Million | 83.67 Million | 119.92 Million | 147.65 Million | - | 72.68 Million |
| Earnings Before Tax Margin | -0.16 | 0.12 | 0.13 | 0.19 | 0.22 | 0.14 |
WRPT
CENTURYPLY
SDRC
GTN-A
001940
YATHARTH